Alnylam Pharmaceuticals
ALNY
#647
Rank
โ‚ฌ30.12 B
Marketcap
233,55ย โ‚ฌ
Share price
-0.77%
Change (1 day)
56.96%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Total assets

Total assets on the balance sheet as of September 2024 : โ‚ฌ4.01 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company's total assets are โ‚ฌ4.01 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alnylam Pharmaceuticals - Total assets on balance sheet (from 2003 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚ฌ3.46 B4.79%
2022-12-31โ‚ฌ3.30 B2.77%
2021-12-31โ‚ฌ3.21 B16.14%
2020-12-31โ‚ฌ2.76 B29.56%
2019-12-31โ‚ฌ2.13 B55.32%
2018-12-31โ‚ฌ1.37 B-17.2%
2017-12-31โ‚ฌ1.66 B38.48%
2016-12-31โ‚ฌ1.20 B-5.32%
2015-12-31โ‚ฌ1.26 B42.85%
2014-12-31โ‚ฌ0.88 B191.51%
2013-12-31โ‚ฌ0.30 B40.09%
2012-12-31โ‚ฌ0.21 B0.13%
2011-12-31โ‚ฌ0.21 B-26.58%
2010-12-31โ‚ฌ0.29 B-12.01%
2009-12-31โ‚ฌ0.33 B-15.32%
2008-12-31โ‚ฌ0.39 B17.32%
2007-12-31โ‚ฌ0.33 B85.93%
2006-12-31โ‚ฌ0.18 B119.09%
2005-12-31โ‚ฌ83.02 M70.36%
2004-12-31โ‚ฌ48.73 M74.39%
2003-12-31โ‚ฌ27.94 M81.32%
2002-12-31โ‚ฌ15.41 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ0.84 B-78.98%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ35.70 B 790.41%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.43 B-14.39%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.88 B-52.92%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ99.29 M-97.52%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ98.73 B 2,361.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ132.65 B 3,207.82%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ39.82 B 893.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel